Xiaqing Xu; Qian Liu; Feifei Yang; Yiqing Zhang; Wanruo Yuan; Wenfang Gao; Liying Ma; Qi Zhang
(The Pharmaceutical Society Of Korea, 2025-12)
5-Fluorouracil (5-FU) remains the most commonly used first-line chemotherapeutic agent for the treatment of esophageal cancer (EC), but its therapeutic efficacy is unsatisfactory. In this study, we found that 5% of ESCC ...